Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 253 - Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 253 - Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group (2,967)
10/2013
10/23/2013CN103360331A Novel lamotrigine pharmaceutical co-crystal and preparation method thereof
10/23/2013CN103356636A Theramutein调节剂 Theramutein moderator
10/17/2013US20130274459 Methods for isolating crystalline form i of 5-azacytidine
10/17/2013US20130274263 Tubulin inhibitors
10/03/2013WO2013143376A1 Quinoline compounds containing 1,2,4-triazine-3,5-dione and use thereof
10/03/2013US20130261123 Novel Substituted Bicyclic Aromatic Compounds as S-Nitrosoglutathione Reductase Inhibitors
10/02/2013CN103333130A Preparation method of 4-amino-6-tert-butyl-3-methylthio-1,2,4-triazine 5 (4H)-ketone
10/02/2013CN103333129A Method for preparing 4-amino-6-tertiary butyl-3-methylmercapto-1,2,4-triazine-5(4H)-ketone
09/2013
09/25/2013CN103319425A Method for synthesizing 4-amino-6-tert-butyl-3-methylthio-1,2,4-triazine-5(4H)-one
09/25/2013CN103319424A Synthesis method of 4-amino-6-tert-butyl-3-methylthio-1,2,4-triazine-5(4H)-one
09/19/2013US20130243698 Radical polarizing agents for dynamic nuclear polarization
09/05/2013US20130231342 Arylcyclopropylamine based demethylase inhibitors of lsd1 and their medical use
09/04/2013CN103275026A High-yield environment-friendly preparation method of acetamino triazinone
09/03/2013US8524896 Chemical compounds
09/03/2013US8524712 Triazinone and diazinone derivatives useful as HSP90 inhibitors
08/2013
08/21/2013CN103254146A Preparation method of metamitron
08/21/2013CN102127056B Tubulin inhibitors
08/14/2013CN103249719A Matrix metalloproteinase inhibitors
08/13/2013US8507670 Matrix metalloproteinase inhibitors
08/01/2013WO2013019731A3 Phosphate prodrugs
07/2013
07/31/2013EP2619185A1 Matrix metalloproteinase inhibitors
07/31/2013EP2619179A1 Matrix metalloproteinase inhibitors
07/31/2013CN103228634A Matrix metalloproteinase inhibitors
07/31/2013CN103224473A Preparation method of triazine ring
07/23/2013US8492540 1,2,4,-triazin-3,5-dione compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
07/10/2013EP2612852A1 Theramutein modulators
07/09/2013US8481715 Methods for isolating crystalline form I of 5-azacytidine
07/03/2013CN102285930B Triazine compound and application thereof in chicken coccidiosis disease control
06/2013
06/20/2013US20130158262 Compounds as Ligands for Transition Metal Complexes and Materials Made Thereof, and Use Therefor
06/13/2013WO2013086467A1 Benzotriazine oxides as drugs targeting mycobacterium tuberculosis
06/13/2013US20130150369 Benzotriazine Oxides as Drugs Targeting Mycobacterium Tuberculosis
06/13/2013US20130150368 Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
06/13/2013US20130150358 Theramutein modulators
06/12/2013CN101674834B Inhibitors of bruton's tyrosine kinase
06/12/2013CN101600683B Therapeutic compounds
06/11/2013US8461080 Aluminum silicate-free, highly concentrated suspension concentrates of metribuzin
06/11/2013CA2683826C Pentacyclic anion salts or tetrazapentalene derivatives and their uses as ionic conducting materials
06/06/2013WO2012140255A3 Rubber composition including a 1,2,4-triazine derivative
06/05/2013EP2598493A1 Matrix metalloproteinase inhibitors
06/05/2013EP2598482A1 Arylcyclopropylamine based demethylase inhibitors of lsd1 and their medical use
05/2013
05/30/2013US20130137661 Gonadotropin Releasing Hormone Receptor Antagonist, Preparation Method Thereof And Pharmaceutical Composition Comprising The Same
05/29/2013CN103124724A Arylcyclopropylamine based demethylase inhibitors of LSD1 and their medical use
05/29/2013CN101466710B Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
05/23/2013WO2013072015A1 Morpholinyl benzotriazine for use in cancer therapy
05/23/2013DE102011118830A1 Morpholinylbenzotriazine Morpholinylbenzotriazine
05/23/2013CA2856103A1 Morpholinyl benzotriazine for use in cancer therapy
05/22/2013CN103119030A Matrix metalloproteinase inhibitors
05/16/2013US20130123262 Novel triazinedione derivatives as gabab receptor modulators
05/14/2013US8440813 Antiviral nucleoside analogs
04/2013
04/25/2013US20130102468 6-acyl-1,2,4-triazine-3,5-dione derivative and herbicides
04/24/2013EP2582684A1 Novel compounds as ligands for transition metal complexes and materials made thereof, and use therefor
04/23/2013US8426588 Phenylalanine derivatives
04/23/2013CA2513123C Hiv inhibiting 1,2,4-triazines
04/10/2013CN103038222A Novel compounds as ligands for transition metal complexes and materials made thereof, and use therefor
04/10/2013CN101230045B Aromatic triazin derivatives and uses thereof
04/09/2013US8415368 Acid secretion inhibitor
04/09/2013CA2704986C Use of an ionic compound, derived from malononitrile as a photoinitiator, radical initiators or catalyser in polymerization processes or as a basic dye
04/04/2013US20130085276 Carboxylation catalysts
04/02/2013US8410098 N-{1-[3-(2-ethoxy-5-(4-ethylpiperazinyl)sulfonylphenyl)-4,5-dihydro-5-OXO-1,2,4-triazin-6-yl]ethyl}butyramide, the preparation method and use thereof
03/2013
03/28/2013WO2013041859A1 Cannabinoid-2-receptor agonists
03/13/2013CN102971302A 6-acyl-1,2,4-triazine-3,5-dione derivative and herbicides
03/12/2013US8394806 2-phenyl pyrazines as tubulin inhibitors
03/06/2013CN102952090A Benzo[1,2,3]triazine ring contained ether compound and its use
03/06/2013CN102952089A Preparation method of metamitron
03/06/2013CN102952080A Benzoheterocycle contained ether compound and its use
02/2013
02/28/2013US20130053559 1,2,4-Triazine Suitable as a Vulcanization Accelerator and Method for Producing Same
02/27/2013EP2560963A1 Derivatives of nitrogen heterocycles, method for preparing same and use thereof in human therapy
02/26/2013US8383824 Heterocyclic antiviral compounds
02/21/2013WO2013023540A1 Triazine compound and use thereof in control of chicken coccidiosis
02/14/2013US20130040928 Nitrogen heterocycle derivatives, preparation thereof and application thereof in human therapeutics
02/07/2013WO2013019731A2 Phosphate prodrugs
02/05/2013US8367038 Therameutin modulators
01/2013
01/31/2013US20130029963 1,2,4-triazine-4-amine derivatives
01/30/2013EP2550261A2 Pyridazine compounds for controlling invertebrate pests
01/30/2013CN102250030B Method for preparing 4-amino-6-methyl-1,2,4triazine-3-ketone
01/23/2013EP2548558A1 Nitrogen-containing condensed heterocyclic as inhibitors of bruton's tyrosine kinase
01/23/2013CN102887869A Application of 3-acylamino-1,2,4-phentriazines to preparation of tumor sensitizer
01/09/2013EP2543376A1 Benzotriazine inhibitors of kinases
01/09/2013EP2543375A1 Pyrrolo-pyrimidine analogues as inhibitors of bruton's tyrosine kinase
01/09/2013EP2542538A1 6-acyl-1,2,4-triazine-3,5-dione derivative and herbicides
01/08/2013US8349835 Aromatic ring fused triazine derivatives and uses thereof
01/08/2013CA2567574C Benzotriazine inhibitors of kinases
01/03/2013US20130005967 Method for preparing (r)-3-(3-fluoro-4-(1-methyl-5,6-dihydro-1,2,4-triazin-4(1h)-yl)phenyl)-5-(substituted methyl)oxazolidin-2-one derivatives
01/03/2013US20130005732 New medical use of triazine derivatives
01/01/2013US8344138 Triazinedione derivatives as GABAB receptor modulators
12/2012
12/19/2012CN102827091A Triazine mercapto derivate as well as preparation method and application thereof
12/12/2012EP2532653A1 Benzo[1,2,4]triazines as protein kinase modulators
12/12/2012EP2531492A1 1,2,4-triazine-4-amine derivatives
12/12/2012CN102822150A 1,2,4-triazine-4-amine derivatives
12/05/2012CN102070545B Method for preparing lamotrigine
11/2012
11/27/2012US8318702 Di(arylamino)aryl compounds
11/27/2012CA2487805C Peptide deformylase inhibitors
11/15/2012WO2012154760A1 Fused heterocyclic compounds as sodium channel modulators
11/15/2012US20120289493 Fused heterocyclic compounds as ion channel modulators
11/15/2012US20120289403 Fluorinated Oxa or Thia Heteroarylalkylsulfide Derivatives for Combating Invertebrate Pests
11/15/2012CA2834164A1 Fused heterocyclic compounds as sodium channel modulators
11/13/2012US8309740 One-pot synthesis of fluorinated ionic liquids
11/07/2012CN102766104A Synthetic method of drug lamotrigine for curing bipolar disorder and epilepsy
10/2012
10/30/2012US8298298 Dyes with changeable solubilities, and methods for their use
10/23/2012CA2564493C Monomer 5,6-diphenyl-1,2,4-triazinic derivatives and the use thereof
1 2 3 4 5 6 7 8 9 10 11 12 ... 30